E Douglas Kramer

1.0k total citations
7 papers, 791 citations indexed

About

E Douglas Kramer is a scholar working on Cardiology and Cardiovascular Medicine, Oncology and Surgery. According to data from OpenAlex, E Douglas Kramer has authored 7 papers receiving a total of 791 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 5 papers in Oncology and 2 papers in Surgery. Recurrent topics in E Douglas Kramer's work include Cancer Treatment and Pharmacology (5 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers) and Cardiac, Anesthesia and Surgical Outcomes (2 papers). E Douglas Kramer is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers) and Cardiac, Anesthesia and Surgical Outcomes (2 papers). E Douglas Kramer collaborates with scholars based in United States, Argentina and Honduras. E Douglas Kramer's co-authors include Joseph J. Sanger, Anne Zeleniuch‐Jacquotte, James L. Speyer, Mariano Rey, J Wernz, Howard S. Höchster, Marleen Meyers, V J Ferrans, Ronald H. Blum and Franco M. Muggia and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

E Douglas Kramer

7 papers receiving 749 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E Douglas Kramer United States	7	632	346	260	152	103	7	791
M.T. Meinardi Netherlands	9	578 0.9×	346 1.0×	195 0.8×	314 2.1×	117 1.1×	10	1.0k
Alessandro Martinoni Italy	10	895 1.4×	380 1.1×	186 0.7×	55 0.4×	266 2.6×	12	993
Peter Stecy United States	6	499 0.8×	154 0.4×	100 0.4×	182 1.2×	196 1.9×	9	658
Courtney L. Bickford United States	5	892 1.4×	510 1.5×	208 0.8×	57 0.4×	213 2.1×	6	1.2k
Mary Kathryn Pierri United States	7	794 1.3×	887 2.6×	283 1.1×	70 0.5×	353 3.4×	16	1.3k
Giulia Bacchiani Italy	11	1.2k 1.8×	491 1.4×	543 2.1×	116 0.8×	285 2.8×	12	1.6k
Engracio P. Cortes United States	13	275 0.4×	439 1.3×	372 1.4×	194 1.3×	40 0.4×	22	901
Fabrizio Villani Italy	18	491 0.8×	455 1.3×	157 0.6×	39 0.3×	60 0.6×	41	942
Gülten Tekuzman Türkiye	15	234 0.4×	334 1.0×	171 0.7×	55 0.4×	59 0.6×	58	737
Olexiy Aseyev Canada	7	495 0.8×	305 0.9×	174 0.7×	64 0.4×	143 1.4×	14	734

Countries citing papers authored by E Douglas Kramer

Since Specialization

Citations

This map shows the geographic impact of E Douglas Kramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Douglas Kramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Douglas Kramer more than expected).

Fields of papers citing papers by E Douglas Kramer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Douglas Kramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Douglas Kramer. The network helps show where E Douglas Kramer may publish in the future.

Co-authorship network of co-authors of E Douglas Kramer

This figure shows the co-authorship network connecting the top 25 collaborators of E Douglas Kramer. A scholar is included among the top collaborators of E Douglas Kramer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Douglas Kramer. E Douglas Kramer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

Rugo, Hope S., Francisco Barrios, Suyapa Bejarano, et al.. (2022). Open-Label, Randomized, Multicenter, Phase III Study Comparing Oral Paclitaxel Plus Encequidar Versus Intravenous Paclitaxel in Patients With Metastatic Breast Cancer. Journal of Clinical Oncology. 41(1). 65–74. 12 indexed citations

Cutler, David L., Francisco Barrios, Marco Chivalan, et al.. (2020). Abstract GS6-01: Oral paclitaxel with encequidar: The first orally administered paclitaxel shown to be superior to IV paclitaxel on confirmed response and survival with less neuropathy: A phase III clinical study in metastatic breast cancer. Cancer Research. 80(4_Supplement). GS6–1. 8 indexed citations

Speyer, James L., Anne Zeleniuch‐Jacquotte, J Wernz, et al.. (1992). ICRF-187 permits longer treatment with doxorubicin in women with breast cancer.. Journal of Clinical Oncology. 10(1). 117–127. 263 indexed citations

Speyer, James L., Joseph J. Sanger, Anne Zeleniuch‐Jacquotte, et al.. (1990). A prospective randomized trial of ICRF-187 for prevention of cumulative doxorubicin-induced cardiac toxicity in women with breast cancer. Cancer Treatment Reviews. 17(2-3). 161–163. 20 indexed citations

Speyer, James L., Michael D. Green, E Douglas Kramer, et al.. (1988). Protective Effect of the Bispiperazinedione ICRF-187 against Doxorubicin-Induced Cardiac Toxicity in Women with Advanced Breast Cancer. New England Journal of Medicine. 319(12). 745–752. 281 indexed citations

Am, Imparato, Riles Ts, Baumann Fg, et al.. (1985). The value of the radionuclide angiogram in the prediction of perioperative myocardial infarction in patients undergoing lower extremity revascularization procedures.. PubMed. 72(3 Pt 2). II13–7. 98 indexed citations

Pasternack, Peter F., Anthony M. Imparato, Thomas S. Riles, et al.. (1984). The value of radionuclide angiography as a predictor of perioperative myocardial infarction in patients undergoing abdominal aortic aneurysm resection. Journal of Vascular Surgery. 1(2). 320–325. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact